Clinical Trial Update: Study of Cipterbin®, Used Alone or With Vinorelbine in Patients With HER2/Neu-overexpressed Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

The Phase 2 trial of Cipterbin used alone or with Vinorelbine in HER2-overexpressed metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Cipterbin
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Shanghai CP Guojian Pharmaceutical Co., Ltd. | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED